SEC Form 4/A · accession 0001214659-17-005550
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John Craig Thompson
Officer — President & CEO · Director
Period of report
Sep 7, 2017
Accepted (ET)
Sep 7, 2017 · 6:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Sep 7, 2017 | P | 10,400 | $1.432 | A | 11,298 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person acquired the shares in the open market at an average cost of $1.432. Shares have been adjusted to reflect the issuer's 1-for-8 reverse stock split effectuated on April 28, 2017. This is an amendment to correct two errors in the original form 4 filed on September 7, 2017.